The Braves opened camp in 2026 hoping for a full season from outfielder/designated hitter Jurickson Profar. He’d missed 80 games in 2025 following a PED suspension but was productive upon returning. With designated hitter Marcell Ozuna out the door, Profar and newly signed outfielder Mike Yastrzemski had plenty of runway to frequent playing time.
Of course, we now know that Profar isn’t likely to play a single game in 2026. He’s staring down yet another PED-related suspension, and the punishment for second-time offenders jumps from 80 games to 162 games. Profar and the MLBPA appear intent on appealing the ban, but there’s no precedent for a suspension being completely overturned.
At best, Profar can probably hope for a slight reduction, and even instances like that are rare. Right-hander Michael Pineda saw a 2019 suspension reduced from 80 to 60 games, but only after providing sufficient evidence that the banned diuretic he took was not used as a masking agent for PEDs. Profar didn’t test positive for a masking agent but rather exogenous testosterone.
Assuming Profar’s season-long ban is upheld, Atlanta will have some decisions to make. The Braves are already down their shortstop and two rotation arms this spring. Ha-Seong Kim required surgery to repair a tendon in his hand after slipping on some ice in the offseason. Righties Spencer Schwellenbach and Hurston Waldrep both underwent elbow surgery to remove loose bodies and/or bone spurs.
The Braves are now also without Profar, who’d been in line for regular at-bats and was hoping to build off the sound .248/.358/.446 batting line (126 wRC+) he logged in 355 plate appearances upon returning from last year’s suspension. The veteran switch-hitter walked at a huge 13.2% clip and only struck out in 15.8% of his plate appearances. He connected on 14 home runs, 16 doubles and a triple while contributing nine steals (in 11 tries) on the bases.
Losing Schwellenbach, Profar, Kim and Waldrep before the halfway point in spring training is a rough way to begin the season for an Atlanta club hoping for better health than in an injury-decimated 2025 campaign. If there’s a silver lining for Braves fans, however, it’s that Profar’s suspension sends him to the restricted list and mandates that he will not be paid his $15MM salary. The Braves are not only off the hook for that $15MM — they’re also spared $3MM of associated luxury taxes they’d have paid to the league.
There’s obviously no guarantee that Atlanta reinvests the full freight of the money they’re now spared. The Braves could opt to lean on in-house solutions to plug their newfound roster gaps, then readdress when the trade deadline rolls around. That’s a defensible strategy, though the counterpoint would be that spending some of those funds on immediate additions would bolster the team’s chances of making it to late July as a contender.
Much of free agency and the trade market has been picked over, but there are some options for president of baseball operations Alex Anthopoulos to explore with his unexpected $15MM of payroll flexibility late in the winter. MLBTR’s Tim Dierkes more briefly touched on this topic in yesterday’s mailbag, but let’s take a look at some more possibilities.
Unlock Subscriber-Exclusive Articles Like This One With a Trade Rumors Front Office Subscription
- Access weekly subscriber-only articles by Tim Dierkes, Steve Adams, and Anthony Franco.
- Join exclusive weekly live chats with Anthony.
- Remove ads and support our writers.
- Access GM-caliber tools like our MLB Contract Tracker
